整容

Investors bet China’s cosmetic surgery industry is next on regulators’ hit list

Shares of top companies fall more than a third amid criticism from Beijing

For evidence of China’s $50bn obsession with cosmetic surgery, look no further than a “little red book”.

That is the English translation of Xiaohongshu, the beauty-focused ecommerce and social media app popular among young Chinese women on which the hashtag #PreAndPostOp has garnered more than 290,000 posts. Many of them flaunt before-and-after photos of overhauled jawlines, plumper lips and reconstructed cheekbones.

But since the start of July, the market value of the country’s three biggest publicly traded medical aesthetics companies has fallen by a third, representing a collective loss of more than $17bn, despite the popularity of cosmetic procedures.

您已閱讀11%(661字),剩餘89%(5211字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×